Enduring Symposium: Essentials of Endovascular Therapy

Enduring Symposium: Essentials of Endovascular Therapy

Self-Assessment Activity

Enduring Online Activity

Recorded at ISET on Wednesday, January 22, 2020
8:00am – 12:25pm

PROVIDER STATEMENT

Provided by North American Center for Continuing Medical Education, LLC, an HMP Company.

For questions regarding this educational activity, please call 609-371-1137 or email info@naccme.com.

Intended Learners

The International Symposium on Endovascular Therapy (ISET) is designed for interventional radiologists, vascular surgeons, interventional cardiologists, interventional neuroradiologists, cardiothoracic surgeons, clinical cardiologists, clinical radiologists, neurologists, internists, nurses and others involved in the treatment of cardiovascular disease.

Learning Objectives

After attending the Focused Symposium: Essentials of Endovascular Therapy at the 32nd Annual International Symposium on Endovascular Therapy (ISET) participants should be able to:

  • List evidence based medicine criteria that reflect the best techniques and devices to treat cardiovascular disease.
  • Explain the benefits of medical management and advances in anticoagulation to improve patient outcomes of endovascular therapy.
  • Assess diagnosis and treatment options for acute, chronic, and superficial venous disease, as well as acute arterial ischemia.
  • Analyze the role of noninvasive testing options in patients with peripheral arterial disease.
  • Differentiate advanced techniques and treatment for pulmonary embolism.
  • Assess treatment options via review of patient case examples for aortic-illiac, femoral popliteal, and tibial peroneal diseases.
CLAIMING CREDIT

To be eligible for credit, participants must complete the online activity by viewing both webcasts posted, completing an online post-test self-assessment, and the online evaluation by April 17, 2021. Upon completing the activity, there will be instructions on how to print a certificate or other documentation of credit.

Release Date: April 17, 2020
Expiration Date: April 17, 2021
Estimated Time to Complete: 4 hours

There is no fee associated with this activity.

ACCREDITATION

In support of improving patient care, North American Center for Continuing Medical Education (NACCME) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

PHYSICIANS

NACCME designates this enduring activity for a maximum of 4.0 AMA PRA Category 1 Credits™.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

UEMS/EACCME CME Credit Recognition

The American Medical Association (AMA) has an agreement of mutual recognition of CME credit with the UEMS. Under the terms of this agreement the European Accreditation Council for Continuing Medical Education (EACCME), the accrediting arm of the UEMS, will convert CME credit for live activities certified by the AMA.

NURSING

This continuing nursing education activity awards up to 4.0 contact hours.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 4.0 contact hours.

PHYSICIAN ASSISTANTS

NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This activity is designated for 4.0 AAPA Category 1 credits. PAs should only claim credit commensurate with the extent of their participation.

American Board of Radiology (ABR) Maintenance of Certification (MOC)

This enduring activity is qualified for SA-CME or SAMs credits by the ABR. This activity is a recording of the below live session at ISET that is fully qualified by the American Board of Radiology in meeting the criteria for self-assessment toward the purpose of fulfilling requirements in the ABR Maintenance of Certification Program (MOC):

Focused Symposium: The Essentials of Endovascular Therapy

Wednesday, January 22, 2020
8:00am – 12:25pm   4.0 credits
ABR Date of Qualification: December 26, 2019
NACD061219-4597

If you have participated in the live activity at ISET and have already claimed SAMs credits for this program, you are not eligible to claim SAMs credits for this enduring activity.

American Board of Surgery (ABS) Maintenance of Certification (MOC)

Achieving a score of 75% or more on this self-assessment will allow the AMA PRA Category 1 Credits™ earned during this activity to count toward self-assessment credits toward Part 2 of the ABS MOC Program.

USE OF PROPRIETARY NAMES

This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.

UNAPPROVED AND/OR INVESTIGATIONAL USES OF DRUGS AND DEVICES

This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the European Medicines Agency (EMA) of the European Union or the Food and Drug Administration (FDA) of the United States. Participants are strongly encouraged to consult approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed during this activity are the opinions of the respective authors, presenters or moderators and do not necessarily reflect the opinions of NACCME.

DISCLAIMERS

The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.

Neither NACCME nor any of its subsidiaries or affiliates is affiliated with, or formally endorsed by a medical society.

The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME or HMP. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS

NACCME, LLC is an independent provider(s) of continuing medical education. NACCME, LLC has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.

NACCME, LLC assures that all educational materials are reviewed to ensure for the absence of commercial bias, fair balance, scientific objectivity, and levels of evidence. The educational activity will not be influenced by commercial organizations and will not conflict with any other scheduled educational activities.

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

Clinical Reviewers

Adam Geronemus, MD
Interventional Radiologist
Miami Cardiac & Vascular Institute
South Miami Heart Center
Miami, Florida

Alex Powell, MD
Interventional Radiologist
Miami Cardiac & Vascular Institute
Miami, Florida

NURSE PLANNER

Susie Seaman, NP
Sharp Rees-Stealy Wound Clinic
San Diego, California

Planning Committee

In addition to the faculty listed below, the planning committee is comprised of: James Benenati, MD, FSIR; Daniel Clair, MD; Ripal T. Gandhi, MD, FSIR, FVSM; Adam Geronemus, MD; William Gray, MD, FACC, FSCAI; Barry Katzen, MD, FACC, FACR, FSIR; Kenia Lynn, PA; Jihad Mustapha, MD, FACC, FSCAI; Richard Neville, MD, FACS; Constantino Peña, MD, FSIR; Alex Powell, MD, FSIR; Ramon Quesada, MD; Brian Schiro, MD; and Susie Seaman, NP; and Chris Bolwell, Caitlin Eastman, MaryEllen Fama, Jennifer Ilcyn, Todd Kunkler, Joanna Tong, and Colleen Waters, NACCME.

Chris Bolwell is a shareholder of GlaxoSmithKline. GlaxoSmithKline is not supporting this activity, nor does any content relate to their product/service.

Ms. Fama, Ms. Ilcyn, Mr. Kunkler, Ms. Tong, and Ms. Waters of NACCME have disclosed no relevant financial relationships with any commercial interests.

Faculty
The faculty has reported the following:

Gary Ansel, MD, FACC: Consultant – Abbott Vascular, Boston Scientific, CR Bard, SurModics, W.L. Gore; Speakers’ Bureau – Medtronic, Boston Scientific, Surmodics, Cook Medical; Other Financial or Material Support – Cook Medical (Royalties)

James F. Benenati, MD, FSIR: Consultant – Penumbra; Major Stock Shareholder – Penumbra; Speakers’ Bureau – Sirtex, Endologix

Daniel Clair, MD: Consultant: BD-Bard, BSC, Elastimed, LimFlow, Medtronic, Venture Medical

James Froehlich, MD - Consultant – Pfizer, Merck, Janssen, Johnson and Johnson, Boehringer-Ingleheim; Grant/Research Support – Blue Cross Blue Shield of Michigan, Pfizer, Janssen

 Ian DelConde, MD, FACC: Speakers' Bureau – Bristol Myers Squibb, J&J, Janssen, Lantheus, Merck

 Ripal T. Gandhi, MD, FSIR, FSVM: Consultant–Medtronic, Bard; Speakers’ Bureau–Boston Scientific; Other Financial or Material Support–Sirtex Proctor.

Mark Garcia, MD: Consultant – BSC, BTG/EKOS, Cook, Merit Medical, Philips/Volcano, Vascular Medcure, Walk Vascular; Grant/ Research Support – BSC, BTG/EKOS; Speakers’ Bureau – BSC, BTG/EKOS, Cook, Philips/Volcano; Major Stock Shareholder – Cagent Vascular, Intact Vascular, Vascular Medcure, Vesper Medical; Other Financial or Material Support – Study PI for ACCESS PTS; BSC: MAB; Cagent Vascular: MAB; Intact Vascular: MAB; Merit Medical: royalties; Philips/Volcano: MAB; Vascular Medcure: SAB; Vesper Medical: CMO, MAB, BOD; Walk Vascular: family member employee

Adam Geronemus, MD: Speakers' Bureau – Bard, Gore, Merit, Penumbra, Sirtex

Bruce Gray, MD has nothing to disclose.

Michael R. Jaff, DO: Consultant – Medtronic, Biotronik, Philips/Volcano, Sanofi, Silk Road Medical, Micell, Vactronix, Venarum, Non-Compensated: Boston Scientific, Abbott Vascular; Major Stock Shareholder – Embolitech, Gemini, PQ Bypass, Primacea, Sano V, Vascular Therapies, EFemoral

Raghu Kolluri, MD, MS, RVT, FSVM has nothing to disclose.

D. Chris Metzger, MD, FACC, FSCAI: Speakers’ Bureau - Abbott, Endologix/ TriVascular, Boston Scientific, Bard, Gore, CSI, Medtronic; Other Financial or Material Support – VIVA Board Member, National PI/Co-PI: Confidence, SAPPHIRE WW, CANOPY

Jihad A. Mustapha, MD, FACC, FSCAI: Consultant - Bard Peripheral Vascular, Boston Scientific, Cardiovascular Systems, Inc., Medtronic, Philips, Terumo; Grant/ Reasearch Support –  Boston Scientific, CardioFlow, PQ Bypass; Major Stock Shareholder – CardioFlow; Other Financial or Material Support - CardioFlow Board of Directors, Micromedical Solutions Chief Medical Officer

Richard Neville, MD, FACS: Consultant – Graftworx, W.L. Gore; Grant/Research Support – Medtronic, W.L. Gore; Scientific Advisory Board – Graftworx, Tissue Analytics, W.L. Gore

Parag Patel, MD, MS, FSIR: Consultant – Medtronic, Penumbra, BD Bard; Speakers’ Bureau – Boston Scientific, Abbott Vascular

Alex Powell, MD, FSIR: Speakers’ Bureau – Bard, Penumbra

Akhilesh Sista, MD: Grant/Research Support – NHLBI (U34 grant, Principal Investigator), Penumbra Inc. (Administered through NYU Radiology Dept); Unpaid Scientific Advisory Board – Thrombolex, Vascular Medcure

George Vatakencherry, MD has nothing to disclose.

Libby Watch, MD: Speakers’ Bureau - BD

Bret N. Wiechmann, MD, FSIR, FAHA: Consultant – Boston Scientific Corporation, Intact Vascular, Morris Innovative, Medtronic, BD/Bard; Grant/Research Support – Intact Vascular, Medtronic; Major Stock Shareholder – PQ Bypas

 

ADA STATEMENT

North American Center for Continuing Medical Education (NACCME) complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609-371-1137.

PRIVACY POLICY

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint providers. NACCME and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2020 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.